Results 191 to 200 of about 1,591,834 (257)

Spatial transcriptomics identifies RBM39 as a gene associated with Gleason score progression in prostate cancer. [PDF]

iScience
Quan Y, Wang M, Zhang H, Lu D, Ping H.
europepmc   +1 more source

Letter from Wesley Gleason, USS Arthur Middleton, to Mother, New Orleans, Louisiana, November 1, 1944

, 1944
Gleason, F. Wesley, Jr.
core  

Impact of Cribriform Pattern on Progression-Free Survival After Radical Prostatectomy in Gleason Score 8-10 Prostate Cancer. [PDF]

Eurasian J Med
Walburn T, Tuaç Y, Aktan Ç, Argun O, Chen LW, Yang DD, Moningi S, Leeman JE, Orio PF, Nguyen PL, D'Amico AV, Sayan M.   +11 more
europepmc   +1 more source

Peritumoral CD117 Immunopositive Mast Cell Density in Prostatic Adenocarcinoma and Its Correlation with the New Gleason Score. [PDF]

Indian J Surg Oncol
Kumar S, Tanveer N, Sharma S, Naz F.
europepmc   +1 more source

Predictors of Gleason score upgrading in patients with a biopsy diagnosis of grade group 1 prostate cancer. [PDF]

Turk J Med Sci
Esen B, Gürses B, Özkan A, Kiliç M, Kordan Y, Esen T, Ertoy Baydar D.   +6 more
europepmc   +1 more source

Therapeutic Consequences of ⁶⁸Ga-PSMA-11-PET/CT in Prostate Cancer in Correlation to the Gleason Score, PSA Value, and D'Amico-Defined Risk Groups. [PDF]

Cancers (Basel)
Eilsberger F, Ebrahimifard A, Spiegel FT, Yousefi BH, Bagheri S, Bowl W, Wang Q, Pfestroff A, Müller L, Luster M, Di Fazio P, Librizzi D.   +11 more
europepmc   +1 more source

UQCRB and LBH are correlated with Gleason score progression in prostate cancer: Spatial transcriptomics and experimental validation. [PDF]

Comput Struct Biotechnol J
Quan Y, Zhang H, Wang M, Ping H.
europepmc   +1 more source

Risk factors for Gleason score upgrade from prostate biopsy to radical prostatectomy. [PDF]

Explor Target Antitumor Ther
Smani S, Sundaresan V, Lokeshwar SD, Choksi AU, Carbonella J, Brito J, Renzulli J, Sprenkle P, Leapman MS.   +8 more
europepmc   +1 more source

High body mass index increases the risk for prostate cancer and high Gleason score in northern Tanzania: data from prostate cancer screening. [PDF]

Ecancermedicalscience
Ngowi BN, Mremi A, Seif M, Bright F, Lyimo G, Uggh I, Mitao MP, Nyongole O, Mbwambo OJ, Gill H, Nyindo M, Mteta KA, Mmbaga BT.   +12 more
europepmc   +1 more source

Prediction of biochemical prostate cancer recurrence from any Gleason score using robust tissue structure and clinically available information. [PDF]

Discov Oncol
Marin LE, Zavaleta-Guzman DI, Gutierrez-Garcia JI, Racoceanu D, Casado FL.   +4 more
europepmc   +1 more source